Latest filing published 27 Feb 2025 for Halozyme Therapeutics, INC., €33k.
Filing timeline
BuySaleInsider track record
Michael J. LaBarre: trading record in brief
This profile gathers the share dealings of Michael J. LaBarre in Halozyme Therapeutics, Inc., where the filings describe the role as senior executive. The record holds 170 filings, for trades running from 3 February 2020 to 27 February 2025.
No open-market purchase appears, only 70 sales worth €22.7M. The rest of the record consists of 26 share grants and 74 option exercises. Since January 2025: no purchases and 6 sales on the market.
The newest entry dates from 27 February 2025: an open-market sale of €33k, in Halozyme Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael J. LaBarre
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 600 shares@ US$58.650.1% of flowCommon StockSEC:0001415889-25-005899:3
- 700 shares@ US$58.670.1% of flowCommon StockSEC:0001415889-25-005899:1
- 9,400 shares@ US$58.091.7% of flowCommon StockSEC:0001415889-25-005899:2
- 1,597 shares@ US$58.250.3% of flowCommon StockSEC:0001415889-25-005899:4
- 100 shares@ US$58.740.0% of flowCommon StockSEC:0001415889-25-005899:5
- 9,300 shares@ US$58.0078.9% of flowCommon StockSEC:0001415889-25-005899:0
- 2,410 shares@ US$57.750.4% of flowCommon StockSEC:0001415889-25-005311:1
- 4,747 shares0Common StockSEC:0001415889-25-005311:0
- 20,891 shares0Common StockSEC:0001415889-25-004509:2
- 6,112 shares0Common StockSEC:0001415889-25-004509:4
- 4,263 shares0Common StockSEC:0001415889-25-004509:6
- 1,304 shares@ US$58.290.2% of flowCommon StockSEC:0001415889-25-004509:1
- 8,721 shares@ US$58.291.6% of flowCommon StockSEC:0001415889-25-004509:3
- 3,103 shares@ US$58.290.6% of flowCommon StockSEC:0001415889-25-004509:5
- 2,164 shares@ US$58.290.4% of flowCommon StockSEC:0001415889-25-004509:7
- 3,386 shares0Common StockSEC:0001415889-25-004509:0
- 4,491 shares@ US$19.980.3% of flowCommon StockSEC:0001415889-24-025233:1
- 9,923 shares@ US$53.741.6% of flowCommon StockSEC:0001415889-24-025233:2
- 77 shares@ US$54.250.0% of flowCommon StockSEC:0001415889-24-025233:3
- 10,000 shares@ US$19.980.6% of flowCommon StockSEC:0001415889-24-025233:4
- 10,000 shares@ US$53.261.6% of flowCommon StockSEC:0001415889-24-025233:5
- 5,509 shares@ US$16.651.4% of flowCommon StockSEC:0001415889-24-025233:0
- 10,000 shares@ US$62.881.8% of flowCommon StockSEC:0001415889-24-023657:1
- 10,000 shares@ US$16.650.5% of flowCommon StockSEC:0001415889-24-023657:2
- 7,963 shares@ US$61.891.4% of flowCommon StockSEC:0001415889-24-023657:3
25 of 169 declarations
